- Home
- ADSE vs GRAL Comparison
ADSE vs GRAL Comparison
Compare ADSE & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- GRAL
- Stock Information
- Founded
- ADSE 1980
- GRAL 2016
- Country
- ADSE Ireland
- GRAL United States
- Employees
- ADSE N/A
- GRAL N/A
- Industry
- ADSE Industrial Specialties
- GRAL
- Sector
- ADSE Consumer Discretionary
- GRAL
- Exchange
- ADSE Nasdaq
- GRAL NYSE
- Market Cap
- ADSE 777.7M
- GRAL 877.1M
- IPO Year
- ADSE N/A
- GRAL N/A
- Fundamental
- Price
- ADSE $13.99
- GRAL $37.20
- Analyst Decision
- ADSE Hold
- GRAL Buy
- Analyst Count
- ADSE 1
- GRAL 3
- Target Price
- ADSE $14.00
- GRAL $26.00
- AVG Volume (30 Days)
- ADSE 98.2K
- GRAL 1.2M
- Earning Date
- ADSE 05-02-2025
- GRAL 05-15-2025
- Dividend Yield
- ADSE N/A
- GRAL N/A
- EPS Growth
- ADSE N/A
- GRAL N/A
- EPS
- ADSE N/A
- GRAL N/A
- Revenue
- ADSE $158,974,606.00
- GRAL $125,595,000.00
- Revenue This Year
- ADSE $107.27
- GRAL $24.65
- Revenue Next Year
- ADSE $57.96
- GRAL $12.88
- P/E Ratio
- ADSE N/A
- GRAL N/A
- Revenue Growth
- ADSE 168.42
- GRAL 34.90
- 52 Week Low
- ADSE $10.17
- GRAL $12.33
- 52 Week High
- ADSE $16.35
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- ADSE 57.66
- GRAL N/A
- Support Level
- ADSE $11.52
- GRAL N/A
- Resistance Level
- ADSE $13.18
- GRAL N/A
- Average True Range (ATR)
- ADSE 1.05
- GRAL 0.00
- MACD
- ADSE 0.22
- GRAL 0.00
- Stochastic Oscillator
- ADSE 98.30
- GRAL 0.00
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.